You're not logged in. Please log in to earn stock or Bitcoin rewards on your prescription purchase.
Kutarvia
Kutarvia (efavirenz, emtricitabine, and tenofovir alafenamide) is a fixed-dose combination medication used for the treatment of HIV-1 infection in adults and pediatric patients. It is designed to provide a comprehensive approach to antiretroviral therapy by combining three active ingredients that work synergistically to suppress viral replication. Kutarvia helps to lower the viral load in the body, improving the immune response and reducing the risk of HIV-related complications.
Rx. Enter your prescription
How would you like to get your prescription? Select an option
Pharmacy pickup
Select from 35,000 pharmacies
Free two-day delivery
Coming soon!
Find a pharmacy near you. Enter your ZIP code
Are you a member? Sign up or log in.
Members have saved
$NaN
using our savings card for instant savings.
Don't pay full retail price and miss out on potential savings. Try it now—you have nothing to lose!
NaNM
worth of Satoshi has been rewarded to our members.
Everyone who signs up enjoys the benefits of earning FREE Bitcoin with every purchase.
How much Bitcoin can you earn with Kutarvia ?
The potential for Bitcoin rewards to increase and appreciate in value is a possibility to consider, which may occur over time.
See the value of your savings today
Today's Value
1 Bitcoin = $NaN
Bitcoin (BTC)
...
USD
$NaN
Adjust Bitcoin's potential value to see how much it could be worth
Potential Value
1 Bitcoin =
Bitcoin (BTC)
...
USD
$NaN
Frequently Asked Questions
How effective is Kutarvia for treating HIV?
Kutarvia is highly effective when taken consistently as part of a comprehensive treatment regimen, leading to a significant reduction in viral load and improved immune function.
Can Kutarvia be taken during pregnancy?
Kutarvia should only be used during pregnancy if the benefits outweigh the risks. Discuss with your healthcare provider for personalized advice.
What should I do if I miss a dose?
If you miss a dose, take it as soon as you remember. If it’s close to your next dose, skip the missed dose and continue with your regular schedule. Do not double up on doses.
Are there any long-term risks associated with Kutarvia?
Long-term use of Kutarvia can lead to potential risks, including liver damage and metabolic changes. Regular monitoring and follow-up with your healthcare provider are essential.
Can I drink alcohol while taking Kutarvia?
While moderate alcohol consumption may not significantly impact Kutarvia's effectiveness, it's best to limit alcohol intake as it can increase the risk of liver toxicity and interfere with medication adherence.
Comprehensive Drug Guide
How Does Kutarvia Work?
- Efavirenz: Inhibits reverse transcriptase, an enzyme critical for the replication of the HIV virus.
- Emtricitabine and tenofovir alafenamide: Both are NRTIs that compete with the virus's natural nucleotides and terminate viral DNA synthesis, preventing viral replication. By combining these three medications, Kutarvia effectively lowers the amount of HIV in the blood.
Common Dosages
- 1 tablet taken once daily, with or without food.
Typical Dosing
- Take 1 tablet of Kutarvia once daily. It can be taken at any time of the day, but consistency is key for maintaining effective levels of the medication in the body.
Typical Dosing
FDA Approved Indications
- Treatment of HIV-1 infection in adults and pediatric patients aged 12 years and older weighing at least 35 kg as part of a comprehensive antiretroviral regimen.
Who Shouldn't Take Kutarvia?
- Known hypersensitivity to efavirenz, emtricitabine, tenofovir alafenamide, or any of the components of the formulation.
- Severe liver disease, as it may worsen liver function.
- Concomitant use with certain medications that may interact adversely, particularly those that are strong inducers or inhibitors of CYP450 enzymes.
Advice From The Pharmacist
- Take Kutarvia exactly as prescribed, and do not skip doses to avoid the development of drug resistance.
- It is important to undergo regular monitoring of liver function and viral load to assess the effectiveness of the treatment.
- Inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.
- Discuss with your healthcare provider if you experience any side effects, particularly if they are severe or persistent.
Side Effects of Kutarvia
Common Side Effects
- Nausea
- Diarrhea
- Fatigue
- Dizziness
- Rash
Uncommon/Severe Side Effects
- Severe allergic reactions (swelling, rash, difficulty breathing)
- Hepatotoxicity (liver damage), which may manifest as yellowing of the skin or eyes, dark urine, or severe abdominal pain.
- CNS effects such as severe dizziness or mental health changes (depression, anxiety).
Risks and Warnings of Kutarvia
- CNS Effects: Efavirenz can cause central nervous system side effects such as dizziness, insomnia, and mood changes. Caution is advised, especially in patients with a history of mental health issues.
- Liver Function: Regular monitoring of liver function is necessary, especially in patients with existing liver disease or those taking other medications that may affect the liver.
- Drug Interactions: Kutarvia can interact with various medications, particularly those metabolized by liver enzymes. A complete medication review is essential to avoid adverse effects.
Interactions with Kutarvia
Common Drug Interactions
- CYP450 Inducers and Inhibitors: Medications that induce or inhibit CYP450 enzymes can significantly affect the metabolism of Kutarvia. Examples include rifampin (inducer) and certain antifungals like ketoconazole (inhibitor).
- Anticonvulsants: Drugs like phenytoin may lower the effectiveness of Kutarvia by inducing liver enzymes.
- Hormonal contraceptives: Kutarvia may reduce the effectiveness of hormonal contraceptives, so alternative contraceptive methods should be considered.
Alternatives to Kutarvia
- Atripla: A similar combination medication that includes efavirenz, emtricitabine, and tenofovir disoproxil fumarate for HIV treatment.
- Triumeq: A combination of abacavir, dolutegravir, and lamivudine for HIV management.
- Biktarvy: A newer combination treatment that includes bictegravir, emtricitabine, and tenofovir alafenamide.
- Descovy: A combination of emtricitabine and tenofovir alafenamide, often used in combination with other antiretrovirals.
